A recent systematic review found that most cases of IGF-II-mediated hypoglycaemia were associated with fibrous tumours (53.2%), followed by non-fibrous hepatic tumours (9%), haemangiopericytomas (8.4%), and mesotheliomas (4.7%) (4). This evidence concerns the gene IGF2 and mesothelioma.